| 000 | 01390 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250513195007.0 | ||
| 264 | 0 | _c19991130 | |
| 008 | 199911s 0 0 eng d | ||
| 022 | _a0093-7754 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCzuczman, M S | |
| 245 | 0 | 0 |
_aCHOP plus rituximab chemoimmunotherapy of indolent B-cell lymphoma. _h[electronic resource] |
| 260 |
_bSeminars in oncology _cOct 1999 |
||
| 300 |
_a88-96 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Murine-Derived |
| 650 | 0 | 4 | _aAntigens, CD20 |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma, Non-Hodgkin _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPilot Projects |
| 650 | 0 | 4 |
_aPrednisolone _xadministration & dosage |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 |
_aVincristine _xadministration & dosage |
| 773 | 0 |
_tSeminars in oncology _gvol. 26 _gno. 5 Suppl 14 _gp. 88-96 |
|
| 999 |
_c10517348 _d10517348 |
||